Detalhe da pesquisa
1.
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.
Blood
; 141(14): 1685-1690, 2023 04 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36608320
2.
VEXAS syndrome: complete molecular remission after hypomethylating therapy.
Ann Hematol
; 103(3): 993-997, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38214707
3.
Steady-state versus chemotherapy-based hematopoietic cell mobilization after anti-CD38-based induction therapy in newly diagnosed multiple myeloma.
Transfusion
; 63(11): 2131-2139, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37850414
4.
[Diagnostics and treatment of clinically relevant paraneoplastic syndromes]. / Diagnostik und Therapie klinisch relevanter paraneoplastischer Syndrome.
Schmerz
; 36(6): 447-457, 2022 Dec.
Artigo
Alemão
| MEDLINE | ID: mdl-36260170
5.
Successful treatment of scleromyxoedema with daratumumab.
Br J Haematol
; 2024 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38471663
6.
Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis.
Br J Haematol
; 198(2): 401-404, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35538912
7.
Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.
Cytotherapy
; 17(4): 473-86, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25573333
8.
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany.
Bone Marrow Transplant
; 2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38480852
9.
Treatment of Acquired von Willebrand Disease due to Extracorporeal Membrane Oxygenation in a Pediatric COVID-19 Patient with Vonicog Alfa: A Case Report and Literature Review.
TH Open
; 7(1): e76-e81, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36846831
10.
Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP.
Blood Adv
; 7(14): 3710-3724, 2023 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37042947
11.
Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group.
Hamostaseologie
; 2023 Dec 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38049124
12.
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
J Clin Oncol
; 41(6): 1193-1199, 2023 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36508302
13.
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
Lancet Haematol
; 10(11): e913-e921, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37858328
14.
Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment.
Blood Adv
; 6(6): 1941-1946, 2022 03 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35008107
15.
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Lancet Haematol
; 9(11): e810-e821, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36328040
16.
Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial.
Clin Cancer Res
; 27(2): 402-407, 2021 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33122344
17.
[Expertenreport Immunthrombozytopenie - Aktuelle Diagnostik und Therapie].
Oncol Res Treat
; 46 Suppl 1: 7-53, 2023.
Artigo
Alemão
| MEDLINE | ID: mdl-36572012
18.
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment - Recommendations from an Expert Group from Austria, Germany, and Switzerland.
Oncol Res Treat
; 46 Suppl 2: 5-44, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36787705